期刊文献+

《抗生素耐药:全球监测报告2014》解读与反思 被引量:47

Interspersion and Learning of Antimicrobial Resistance:Global Report on Surveillance 2014 from WHO
原文传递
导出
摘要 目的借鉴世界卫生组织《抗生素耐药:全球监测报告2014》,对我国抗菌药物管理提出合理建议。方法分析世界卫生组织(World Health Organization,WHO)报告和《美国2013年抗生素耐药性威胁》,结合我国相关文献,进行对照分析。结果当下抗生素耐药情况已经非常严峻,社区获得性和医院治病性细菌感染的致病菌耐药和结核、疟疾、HIV和流感等专项疾病耐药形势依旧严峻。我国细菌耐药不容乐观,必须加强管理。WHO和美国疾病防治中心(Centers for Disease Control,CDC)都为应对抗生素耐药提出了相对完备的建议。WHO认为抗生素耐药的形式是严峻的,但还不至于令人绝望。全球应该能够解决该问题并将其控制住。结论中国应当在加强抗菌药物临床应用的严格管控、加强对欠发达地区和基层医疗机构的软硬件与信息建设和提高全社会对抗菌药物严格使用的认同上做工作。 Objective According to the recommendations of Antimicrobial Resistance: Global Report on Surveillance 2014 , some suggestions was given here to antibacterial worship.Methods By interpreting Antimicrobial Resistance: Global Report on Surveillance 2014, Antibiotic Resistance Threats in The United States 2013 and some other re ports from PRC, we contradistinguished and analysed the situation of antibacterial resistance in PRC.Results The situation of antibacterial resistance was hard both in domestic region and world-wide. The community and hospital acquired an tibacterial resistance and the control of tuberculosis, malaria, HIV and influenza were severe. World Health Organization (WHO) and the CDC of USA have also given good advices to deal with the pressing problem. WHO believed that though the situation was harsh, we had the capacity to surmount the big trouble.Conelusiorts We should strengthen the force of antibacterial worship, especially in undeveloped area, by furnishing them enough devices and education to fulfil/the needs of inhibition of antibacterial resistance.
出处 《华南国防医学杂志》 CAS 2014年第8期814-817,共4页 Military Medical Journal of South China
关键词 世界卫生组织 抗生素耐药 报告 借鉴 WHO Antibacterial resistance,Surveillance report,Quotation
  • 相关文献

参考文献9

  • 1WHO. Antimicrobial Resistance: Global Report on Surveillance 2014 [ R/OL]. [ 2014-115-05 ]. http://www, who. int/drugresis- tance/documents/surveillancereport/en/WHO. WHO Global Strategy for Containment of Antimicrobial.
  • 2Resistance[R/OL]. [2014-05- 05]. http://www, who. int/drugre- sistance/WH O_Global_St rat egy_English, pdf.
  • 3WHO. Combating Drug Resistance :No Action Today, No Cure Tomorrow [R/OL]. [ 2014-05-05 ]. http://www, who. int/ world-health-day/2011/en/.
  • 4肖书念,卓超,苏丹虹,倪语星,孙景勇,汪复,朱德妹,胡付品,徐英春,张小江,俞云松,杨青,陈中举,孙自镛,张朝霞,季萍,单斌,杜艳,张泓,孔菁,徐元宏,沈继录,王传清,王爱敏,贾蓓,黄文祥,魏莲花,吴玲,胡云建,艾效曼.2011年中国CHINET克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2013,13(5):331-336. 被引量:25
  • 5汪复,朱德妹,胡付品,蒋晓飞,胡志东,李全,孙自镛,陈中举,徐英春,张小江,王传清,王爱敏,倪语星,孙景勇,褚云卓,俞云松,林洁,徐元宏,沈继录,苏丹虹,卓超,魏莲花,吴玲,张朝霞,季萍,张泓,孔菁,胡云建,艾效曼,单斌,杜艳.2012年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2013,13(5):321-330. 被引量:465
  • 6Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumonia: a report of 2 cases and a brief review of the literature[J].Clin Infect Dis,2009,49(2):271-274.
  • 7Antibiotic Resistance Threats in The United States 2013[R/OL]. [2014-05-05 ]. http://www, cdc. gov/drugresistance/threat-re- port-2013/.
  • 8杨红茹,齐顺祥,刘艳芳,刘兰芬,邸科前.人群甲型流感病毒M2蛋白变异与金刚烷胺耐药性分析[J].中国现代医学杂志,2008,18(23):3468-3471. 被引量:6
  • 9肖永红,沈萍,魏泽庆,陈云波,孔海深,杨青,张伟丽,陈晓,李兰娟.Mohnarin 2011年度全国细菌耐药监测[J].中华医院感染学杂志,2012,22(22):4946-4952. 被引量:366

二级参考文献35

  • 1奥野良信,万献尧,毕丽岩.金刚烷胺[J].日本医学介绍,2004,25(7):307-309. 被引量:20
  • 2卓超,苏丹虹,倪语星,孙景勇,俞云松,杨青,孙自镛,简翠,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,徐元宏,沈继录,徐英春,孙宏莉,张泓,李万华,单斌,杜艳,张朝霞,季萍,贾蓓,黄文祥,魏莲花,吴玲,胡云建,艾效曼.2009年中国CHINET大肠埃希菌和克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):430-435. 被引量:81
  • 3XIONG Zi-zhong ZHU De-mei WANG Fu ZHANG Ying-yuan.CTX-M-14, CTX-M-24 and resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates[J].Chinese Medical Journal,2006(2):160-164. 被引量:13
  • 4蓝雨,李梓,董丽波,张烨,温乐英,张彦明,王敏,郭元吉,舒跃龙.中国H3N2亚型流感病毒烷胺类药物耐药性研究[J].中华实验和临床病毒学杂志,2006,20(2):21-23. 被引量:25
  • 5CLSI Performance standards for antimicrobial susceptibility testing[S]. Twenty second Informational supplement M100- S22 2012,32(3).
  • 6European Committee on Antimicrobial susceptibility testing, Breakpoint tables for interpretation of MICs and zone diame- ters[S]. Version 2, 2012, valid from 2012-01-01.
  • 7Bush K. Alarming β-lactamase mediated resistance in multi- drug-resistant Enterobacteraceae[J]. Curr Opinion Microbi- oh 2010, 13(5): 558-564.
  • 8Nordmann P, Dortet L, Poirel L. Carbepenem resistance in Enterobacteriaceae: here is the storm! [J]. Trends Mol Med, 2012, 18(6): 263-271.
  • 9Hu FP, Chen SD, Xu XG, et al. Emergence of carbapenem resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012,61 (Ptl) : 132-136.
  • 10Yang Q, Wang H, Sun H, et al. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased suseep tibility to carbapenems: results from large hospital-based sur veillance studies in China[J]. Antimicrob Agents Chemoth er, 2010, 54(1):573-577.

共引文献840

同被引文献399

引证文献47

二级引证文献256

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部